Exact Mass: 394.0689

Exact Mass Matches: 394.0689

Found 47 metabolites which its exact mass value is equals to given mass value 394.0689, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Diflufenican

N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]pyridine-3-carboxamide

C19H11F5N2O2 (394.0741)


CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5369; ORIGINAL_PRECURSOR_SCAN_NO 5368 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5374; ORIGINAL_PRECURSOR_SCAN_NO 5371 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5368; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5376; ORIGINAL_PRECURSOR_SCAN_NO 5375 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5337; ORIGINAL_PRECURSOR_SCAN_NO 5333 CONFIDENCE standard compound; INTERNAL_ID 4010 CONFIDENCE standard compound; INTERNAL_ID 2315 CONFIDENCE standard compound; INTERNAL_ID 8384

   

5-Butyrylphosphouridine

5-Butyrylphosphouridine

C13H19N2O10P (394.0777)


   

Prostalidin A

Prostalidin A

C21H14O8 (394.0689)


   

Tetracenomycin B3

Tetracenomycin B3

C21H14O8 (394.0689)


   

Tetracenomycin D3 methylester

Tetracenomycin D3 methylester

C21H14O8 (394.0689)


   

JNJ-7706621

4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide

C15H12F2N6O3S (394.066)


   

Sch 50673

Sch 50673

C21H14O8 (394.0689)


   

58G

58G

C21H14O8 (394.0689)


   

Demethyltorosaflavone C

cis-(+-)-2-(3,4-Dihydroxyphenyl)-5b,8a-dihydro-5,7-dihydroxy-6-methyl-4H,8H-cyclopenta[4,5]furo[3,2-g]-1-benzopyran-4,8-dione

C21H14O8 (394.0689)


   

Maybridge1_008234

Maybridge1_008234

C16H12F6N2O3 (394.0752)


   

Oprea1_016573

Oprea1_016573

C18H20Cl2N4S (394.0786)


   

Q63409042

Q63409042

C21H14O8 (394.0689)


   

Preussomerin I

Preussomerin I

C21H14O8 (394.0689)


   

oxalicumone E

oxalicumone E

C18H18O8S (394.0722)


   

SCHEMBL16226573

SCHEMBL16226573

C21H14O8 (394.0689)


   

10-Bromo-7,12-diacetoxy-Delta2,3-lauren

10-Bromo-7,12-diacetoxy-Delta2,3-lauren

C19H23BrO4 (394.078)


   

Diflufenican

Diflufenican

C19H11F5N2O2 (394.0741)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 116

   

Daphnoretine Acetate

Daphnoretine Acetate

C21H14O8 (394.0689)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102

   

7-O-acetyldaphnoretin

6-Methoxy-2-oxo-3-(2-oxochromen-7-yloxy)chromen-7-yl acetate

C21H14O8 (394.0689)


Origin: Plant, Coumarins

   

2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE

2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE

C18H19ClN2O4S (394.0754)


   

phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate

phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate

C20H14N2O5S (394.0623)


   

2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine

2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine

C17H18N2O5S2 (394.0657)


   

Gonyautoxin II

Gonyautoxin II

C10H16N7O8S (394.0781)


From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.

   

2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine

2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine

C17H18N2O5S2 (394.0657)


   

1,1-DIBENZOYLFERROCENE

1,1-DIBENZOYLFERROCENE

C24H18FeO2 (394.0656)


   

DPPH

DPPH

C18H12N5O6 (394.0788)


   

2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid

2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid

C20H14N2O5S (394.0623)


   

4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide

4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide

C19H14N4O4S (394.0736)


   

4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H20Cl2N4S (394.0786)


   

Aklanonate(2-)

Aklanonate(2-)

C21H14O8-2 (394.0689)


   

2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester

2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester

C17H18N2O5S2 (394.0657)


   

N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide

N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide

C17H18N2O5S2 (394.0657)


   

N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide

N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide

C21H15ClN2O4 (394.072)


   

(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile

(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile

C22H16Cl2N2O (394.064)


   

ARN19874

ARN19874

C19H14N4O4S (394.0736)


ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].

   

{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate

{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate

C19H23BrO4 (394.078)


   

[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate

[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate

C19H23BrO4 (394.078)


   

6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate

6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate

C21H14O8 (394.0689)


   

methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

C21H14O8 (394.0689)


   

(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

C21H14O8 (394.0689)


   

(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid

(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid

C21H14O8 (394.0689)


   

methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

C21H14O8 (394.0689)


   

(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione

(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione

C21H14O8 (394.0689)


   

1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate

1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate

C18H18O8S (394.0722)


   

(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

C21H14O8 (394.0689)


   

1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

C18H18O8S (394.0722)


   

1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

C18H18O8S (394.0722)